HUP0301697A3 - Oral solid dose vaccine - Google Patents
Oral solid dose vaccineInfo
- Publication number
- HUP0301697A3 HUP0301697A3 HU0301697A HUP0301697A HUP0301697A3 HU P0301697 A3 HUP0301697 A3 HU P0301697A3 HU 0301697 A HU0301697 A HU 0301697A HU P0301697 A HUP0301697 A HU P0301697A HU P0301697 A3 HUP0301697 A3 HU P0301697A3
- Authority
- HU
- Hungary
- Prior art keywords
- oral solid
- solid dose
- dose vaccine
- vaccine
- oral
- Prior art date
Links
- 239000007787 solid Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0020089.9A GB0020089D0 (en) | 2000-08-15 | 2000-08-15 | Vaccine Composition |
PCT/IB2001/001711 WO2002013858A1 (en) | 2000-08-15 | 2001-08-14 | Oral solid dose vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0301697A2 HUP0301697A2 (hu) | 2003-08-28 |
HUP0301697A3 true HUP0301697A3 (en) | 2004-11-29 |
Family
ID=9897656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0301697A HUP0301697A3 (en) | 2000-08-15 | 2001-08-14 | Oral solid dose vaccine |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040013695A1 (hu) |
EP (1) | EP1309344A1 (hu) |
JP (1) | JP2004506020A (hu) |
KR (1) | KR20030031978A (hu) |
CN (1) | CN1842345A (hu) |
AU (2) | AU8616801A (hu) |
BR (1) | BR0113301A (hu) |
CA (1) | CA2424160A1 (hu) |
GB (1) | GB0020089D0 (hu) |
HU (1) | HUP0301697A3 (hu) |
IL (1) | IL154404A0 (hu) |
MX (1) | MXPA03001392A (hu) |
NO (1) | NO20030713L (hu) |
NZ (1) | NZ524164A (hu) |
PL (1) | PL362481A1 (hu) |
WO (1) | WO2002013858A1 (hu) |
ZA (1) | ZA200301210B (hu) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
US20050201981A1 (en) * | 2004-03-10 | 2005-09-15 | Chih-Ping Liu | Method of optimizing treatment with interferon-tau |
US20050084478A1 (en) * | 2000-10-17 | 2005-04-21 | Chih-Ping Liu | Combination therapy using interferon-tau |
US20050118137A1 (en) * | 2000-07-19 | 2005-06-02 | Chih-Ping Liu | Method of treatment using interferon-tau |
US20040247565A1 (en) * | 2000-07-19 | 2004-12-09 | Chih-Ping Liu | Method of treatment using interferon-tau |
US20050118138A1 (en) * | 2000-07-19 | 2005-06-02 | Chih-Ping Liu | Method of treatment using interferon-tau |
US20050226845A1 (en) * | 2004-03-10 | 2005-10-13 | Chih-Ping Liu | Method of treatment using interferon-tau |
US7431920B2 (en) * | 2000-07-19 | 2008-10-07 | Pepgen Corporation | Method of treating IL-10 deficiency |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
DK2116257T3 (da) | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
US20050226894A1 (en) * | 2002-01-15 | 2005-10-13 | Jensen-Jarolim Erika | Oral vaccination |
DE10224086A1 (de) | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
MXPA05005528A (es) | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
JP4688787B2 (ja) | 2003-02-28 | 2011-05-25 | アルカベロ アクチェセルスカプ | 糖類マトリックスを有する剤形 |
CA2542332C (en) | 2003-10-16 | 2013-03-12 | Stephen John Ralph | Immunomodulating compositions and uses therefor |
US20060078942A1 (en) * | 2004-03-10 | 2006-04-13 | Pepgen Corporation | Method of treatment using interferon-tau |
US20080025948A1 (en) * | 2004-03-10 | 2008-01-31 | Chih-Ping Liu | Methods of Treatment Using Interferon-Tau |
US20060115499A1 (en) * | 2004-09-27 | 2006-06-01 | Alk-Abello A/S | Liquid allergy vaccine formulation for oromucosal administration |
EP1933867A1 (en) | 2005-10-04 | 2008-06-25 | Alk-Abello A/S | Solid vaccine formulation |
EP1854478A1 (en) * | 2006-05-12 | 2007-11-14 | Cytos Biotechnology AG | Nicotine-carrier vaccine formulation |
WO2009034110A1 (en) | 2007-09-11 | 2009-03-19 | Kobenhavns Universitet | Prevention of type 1 diabetes by administration of gliadin |
GB201009273D0 (en) * | 2010-06-03 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel vaccine |
FR2960781B1 (fr) * | 2010-06-07 | 2013-11-22 | Sanofi Pasteur | Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue |
CN108434089B (zh) | 2010-10-08 | 2020-06-16 | R·P·舍勒科技有限责任公司 | 使用淀粉的口服疫苗快速溶解剂型 |
US9044498B2 (en) | 2010-12-02 | 2015-06-02 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
JP6034798B2 (ja) | 2010-12-02 | 2016-11-30 | オンコリティクス バイオテク,インコーポレーテッド | 液体ウイルス製剤 |
WO2012103464A2 (en) * | 2011-01-28 | 2012-08-02 | Brian Pulliam | Oral thin film vaccine preparation |
CA2865551C (en) * | 2012-03-05 | 2021-01-12 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport | Methods and compositions for stabilizing dried biological materials |
WO2015013549A1 (en) * | 2013-07-25 | 2015-01-29 | Invado Pharmaceuticals, LLC | Treating oral inflammation, injury or pain |
KR102411781B1 (ko) * | 2013-12-31 | 2022-06-22 | 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) | 단일 바이알 백신 제형 |
EP2952200A1 (en) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen for prophylactic treatment of allergy |
US10722570B2 (en) | 2015-11-27 | 2020-07-28 | Nitto Denko Corporation | Dried influenza vaccine preparation and method for producing dried influenza vaccine preparation |
TW201722472A (zh) | 2015-11-27 | 2017-07-01 | Nitto Denko Corp | 口腔內投與用疫苗醫藥組合物及口腔內投與用疫苗醫藥組合物之製造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4636385A (en) * | 1985-02-15 | 1987-01-13 | The Wistar Institute Of Anatomy & Biology | Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection |
GB9722682D0 (en) * | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
EA005952B1 (ru) * | 1999-08-17 | 2005-08-25 | Смитклайн Бичем Байолоджикалз С.А. | Ослабленная популяция ротавирусов и содержащая ее вакцинная композиция |
KR100366608B1 (ko) * | 2000-02-15 | 2003-01-09 | 마스터진(주) | 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신 |
-
2000
- 2000-08-15 GB GBGB0020089.9A patent/GB0020089D0/en not_active Ceased
-
2001
- 2001-08-14 AU AU8616801A patent/AU8616801A/xx active Pending
- 2001-08-14 PL PL01362481A patent/PL362481A1/xx unknown
- 2001-08-14 US US10/344,798 patent/US20040013695A1/en not_active Abandoned
- 2001-08-14 CN CNA018173926A patent/CN1842345A/zh active Pending
- 2001-08-14 NZ NZ524164A patent/NZ524164A/en unknown
- 2001-08-14 WO PCT/IB2001/001711 patent/WO2002013858A1/en not_active Application Discontinuation
- 2001-08-14 JP JP2002518997A patent/JP2004506020A/ja active Pending
- 2001-08-14 AU AU2001286168A patent/AU2001286168B2/en not_active Ceased
- 2001-08-14 KR KR10-2003-7002236A patent/KR20030031978A/ko not_active Application Discontinuation
- 2001-08-14 IL IL15440401A patent/IL154404A0/xx unknown
- 2001-08-14 EP EP01965535A patent/EP1309344A1/en not_active Withdrawn
- 2001-08-14 BR BR0113301-2A patent/BR0113301A/pt not_active IP Right Cessation
- 2001-08-14 CA CA002424160A patent/CA2424160A1/en not_active Abandoned
- 2001-08-14 MX MXPA03001392A patent/MXPA03001392A/es unknown
- 2001-08-14 HU HU0301697A patent/HUP0301697A3/hu unknown
-
2003
- 2003-02-13 ZA ZA200301210A patent/ZA200301210B/en unknown
- 2003-02-14 NO NO20030713A patent/NO20030713L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0113301A (pt) | 2003-07-15 |
HUP0301697A2 (hu) | 2003-08-28 |
GB0020089D0 (en) | 2000-10-04 |
NO20030713L (no) | 2003-04-11 |
IL154404A0 (en) | 2003-09-17 |
KR20030031978A (ko) | 2003-04-23 |
AU8616801A (en) | 2002-02-25 |
AU2001286168B2 (en) | 2004-09-23 |
ZA200301210B (en) | 2004-03-12 |
WO2002013858A1 (en) | 2002-02-21 |
NO20030713D0 (no) | 2003-02-14 |
JP2004506020A (ja) | 2004-02-26 |
NZ524164A (en) | 2004-10-29 |
CN1842345A (zh) | 2006-10-04 |
CA2424160A1 (en) | 2002-02-21 |
PL362481A1 (en) | 2004-11-02 |
US20040013695A1 (en) | 2004-01-22 |
MXPA03001392A (es) | 2004-12-13 |
EP1309344A1 (en) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8616801A (en) | Oral solid dose vaccine | |
ZA200003121B (en) | Flash-melt oral dose formulations. | |
HUP0203204A3 (en) | Oral dosage forms | |
GB0020953D0 (en) | Vaccine | |
HUP0301043A3 (en) | Vaccine | |
IL155072A0 (en) | Vaccine | |
AP2002002700A0 (en) | Vaccine composition | |
AU1591402A (en) | Vaccine | |
GB0014288D0 (en) | Vaccine | |
HUP0401599A3 (en) | Extended release oral dosage form | |
EP1429615A4 (en) | ORAL VACCINES | |
EP1357898A4 (en) | ORAL DOSAGE FORM WITH ENHANCED REGULATED RELEASE | |
GB0026334D0 (en) | Vaccine | |
GB0014845D0 (en) | Vaccine | |
GB0025694D0 (en) | Vaccine | |
GB0003082D0 (en) | Vaccine | |
GB9911823D0 (en) | New vaccine formulations | |
GB0015722D0 (en) | Vaccine | |
GB0006693D0 (en) | Vaccine | |
GB0014497D0 (en) | Oral dosage form | |
HK1047232A1 (zh) | 口服劑型 | |
GB0015935D0 (en) | Vaccine | |
GB0008029D0 (en) | New vaccine formulations | |
GB9925069D0 (en) | Oral dosage form | |
PL341178A1 (en) | Oral pharmaceutical dosage forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |